Piperidine

Piperidine

SCHEMBL3005686

C1CCNCC1.CCN

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperidine SCHEMBL11775250 1.00 ALDH1A1 (0.60) —
Piperidine SCHEMBL27896621 1.00 ALDH1A1 (0.60) —
Piperidine SCHEMBL9800122 1.00 ALDH1A1 (0.60) —
Pyrrolidine SCHEMBL2463793 0.97 — —
Piperidine SCHEMBL7523716 0.88 ALDH1A1 (0.53) —
Piperidine SCHEMBL28074884 0.87 ALDH1A1 (0.45) —
Piperidine SCHEMBL28647712 0.86 ALDH1A1 (0.69) —
Piperidine SCHEMBL27491426 0.86 — —
Piperidine SCHEMBL8740912 0.83 ALDH1A1 (0.64) —
Piperidine SCHEMBL4128881 0.83 ALDH1A1 (0.64) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023217237-A1 LIPID COMPOUND, AND COMPOSITION, PREPARATION AND USE THEREOF 苏州慧疗生物医药科技有限公司 2023-11-16 — — WO disclosed
CN-111909108-B Biphenyl compound and preparation method and medical application thereof 中国药科大学 2023-05-02 — — CN disclosed
CN-218392795-U High-efficient heat recovery unit 宿迁市振兴化工有限公司 2023-01-31 — — CN disclosed
CN-213335671-U Heat energy recycling device 宿迁市振兴化工有限公司 2021-06-01 — — CN disclosed
WO-2021043116-A1 BIPHENYL COMPOUNDS, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 中国药科大学 2021-03-11 — — WO disclosed
CN-111909108-A Biphenyl compound and preparation method and medical application thereof 中国药科大学 2020-11-10 — — CN disclosed
US-20100190824-A1 Novel Substituted Piperidones as HSP Inducers TORRENT PHARMACEUTICALS LTD. (IN) 2010-07-29 — — US disclosed
EP-2178835-A1 NOVEL SUBSTITUTED PIPERIDONES AS HSP INDUCERS Torrent Pharmaceuticals Ltd (IN) 2010-04-28 — — EP disclosed
WO-2009004650-A1 NOVEL SUBSTITUTED PIPERIDONES AS HSP INDUCERS TORRENT PHARMACEUTICALS LTD. (IN) 2009-01-08 — — WO disclosed
EP-0512831-B1 Fibrinogen receptor antagonists MERCK & CO INC (US) 1999-09-22 — — EP disclosed
WO-1994009029-A1 FIBRINOGEN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1994-04-28 — — WO disclosed
US-5281585-A Secondary amide containing antagonist MERCK & CO., INC. (US) 1994-01-25 — — US disclosed
WO-1992019595-A1 FIBRINOGEN RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1992-11-12 — — WO disclosed
EP-0512831-A1 Fibrinogen receptor antagonists MERCK & CO. INC. (US) 1992-11-11 — — EP disclosed
US-5066691-A Polyvinyl butyral and epoxidized polybutadiene blend; tracking resistance HITACHI CHEMICAL CO., LTD. (JP) 1991-11-19 — — US disclosed
Send feedback